Occupational exposure to hazardous medicinal products: the evidence, legislation and the change required to protect healthcare workers.About this Event
Every day, healthcare staff prepare, administer, and dispose of hazardous medicinal products (HMPs), including cytotoxics, immunotherapies and antineoplastic drugs. Occupational exposure is associated with serious long term health effects, and yet there is no recognised national definition of these substances in the UK, no national list, and no legal requirement for the closed system transfer devices that prevent exposure a the point of handling.
This full day conference at the Royal College of Physicians brings together clinicians, employers, researchers and policymakers to examine the evidence and what a national standard should look like.
Speakers to be announced.
Programme:
- 09:30 Registration and Refreshments
- 10:00 Opening Remarks
- [Sessions]
- 16:00 Close
- 16:00 to 17:00 Networking Reception
Who should attend?
This conference is intended for oncology and haematology nurses, chemotherapy and aseptic services pharmacists and Ph*rm*cy technicians, occupational health practitioners, health and safety leads, infection prevention and control teams, procurement and medicines management leads, NHS trust and health board managers, and researchers and policymakers with an interest in occupational health.
The Royal College of Physicians, 11 Saint Andrews Place, London, NW1 4LE. Full accessibility information is available. Please advise of any dietary or access requirements when registering.
The Safer Healthcare Biosafety Network is a coalition of clinical, professional and industry bodies working to improve protections for healthcare staff who handle hazardous medicines.
Event venue
Royal College of Physicians, 11 Saint Andrews Place, London, United Kingdom
Concerts, fests, parties, meetups — all the happenings, one place.